The company is playing an expanded role in the projects it delivers to clients. How will that translate into an enhanced value proposition for a new investor?
Bluewater Bio has had its strongest first half in a decade, as it looks for a strategic investor to support its next phase of growth. The company predicts that it will generate £6.7 million of EBITDA on £40 million of revenues in 2025, more than 90% of which is already in the orderbook.
Please complete the form and one of our technology team will get back in touch with you as soon as possible:
Please complete the form and one of our technology team will get back in touch with you as soon as possible:
Please complete the form and one of our technology team will get back in touch with you as soon as possible:
Please complete the form with as much detail as possible about your project and one of our technology team will get back in touch with you as soon as possible:
Please complete the form and one of our technology team will get back in touch with you as soon as possible:
